Algert Global’s Dyne Therapeutics DYN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.32M | Buy |
558,896
+82,889
| +17% | +$789K | 0.11% | 304 |
|
2025
Q1 | $4.98M | Buy |
476,007
+395,084
| +488% | +$4.13M | 0.12% | 277 |
|
2024
Q4 | $1.91M | Sell |
80,923
-14,037
| -15% | -$331K | 0.04% | 622 |
|
2024
Q3 | $3.41M | Sell |
94,960
-2,410
| -2% | -$86.6K | 0.09% | 379 |
|
2024
Q2 | $3.44M | Buy |
97,370
+69,947
| +255% | +$2.47M | 0.11% | 291 |
|
2024
Q1 | $779K | Sell |
27,423
-133,581
| -83% | -$3.79M | 0.03% | 682 |
|
2023
Q4 | $2.14M | Buy |
161,004
+2,291
| +1% | +$30.5K | 0.09% | 395 |
|
2023
Q3 | $1.42M | Sell |
158,713
-80,359
| -34% | -$720K | 0.07% | 482 |
|
2023
Q2 | $2.69M | Buy |
239,072
+47,200
| +25% | +$531K | 0.12% | 279 |
|
2023
Q1 | $2.21M | Buy |
191,872
+38,227
| +25% | +$440K | 0.1% | 308 |
|
2022
Q4 | $1.78M | Sell |
153,645
-1,450
| -0.9% | -$16.8K | 0.1% | 332 |
|
2022
Q3 | $1.97M | Buy |
155,095
+136,540
| +736% | +$1.73M | 0.12% | 274 |
|
2022
Q2 | $127K | Buy |
+18,555
| New | +$127K | 0.01% | 1084 |
|